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extract on fructose-induced protein glycation and
oxidation-dependent damages to albumin in vitro
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Abstract
Background: The accumulation of advanced glycation end products (AGEs) in body tissue has been implicated in
the progression of age-related diseases. Inhibition of AGE formation is the imperative approach for alleviating diabetic
complications. Clitoria ternatea extract (CTE) has been demonstrated to possess anti-diabetic activity. However, there is no
scientific evidence supporting its anti-glycation activity. The objective of this study was to determine the inhibitory effect of
CTE on fructose-induced formation of AGEs and protein oxidation. Antioxidant activity of CTE was also assessed by various
methods.
Methods: The aqueous extract of CTE (0.25-1.00 mg/ml) was measured for the content of total phenolic compounds,
flavonoid, and anthocyanin by Folin-Ciocalteu assay, AlCl3 colorimetric method, and pH differential method, respectively.
The various concentrations of CTE were incubated with BSA and fructose at 37°C for 28 days. The formation of fluorescent
AGEs, the level of fructosamine, protein carbonyl content, and thiol group were measured. The in vitro antioxidant activity
was measured by the 1,1-diphenyl 2-picrylhydrazyl (DPPH) scavenging activity, trolox equivalent antioxidant capacity (TEAC),
ferric reducing antioxidant power (FRAP), hydroxyl radical scavenging activity (HRSA), superoxide radical scavenging activity
(SRSA), and ferrous ion chelating power (FICP).
Results: The results demonstrated that the content of total phenolics, flavonoids and total anthocyanins in CTE was 53 ±
0.34 mg gallic acid equivalents/g dried extract, 11.2 ± 0.33 mg catechin equivalents/g dried extract, and 1.46 ± 0.04 mg
cyanidin-3-glucoside equivalents/g dried extract, respectively. Moreover, CTE (0.25-1.00 mg/ml) significantly inhibited the
formation of AGEs in a concentration-dependent manner. CTE also markedly reduced the levels of fructosamine and the
oxidation of protein by decreasing protein carbonyl content and preventing free thiol depletion. In the DPPH radical
scavenging activity and SRSA, CTE had the IC50 values of 0.47 ± 0.01 mg/ml and 0.58 ± 0.04 mg/ml. Furthermore, the
FRAP and TEAC values of CTE were 0.38 ± 0.01 mmol FeSO4 equivalents/mg dried extract and 0.17 ± 0.01 mg trolox
equivalents/mg dried extract. However, CTE showed weak scavenging activity on hydroxyl radical and a weak
antioxidant iron chelator.
Conclusions: The results showed that CTE has strong antiglycation and antioxidant properties and might have
therapeutic potentials in the prevention of AGE-mediated diabetic complications.
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Background
Diabetes Mellitus (DM) is a group of metabolic diseases
characterized by hyperglycemia, dyslipidemia, and
abnormal protein metabolism that result from defects
in both insulin secretion and/or insulin action. Chronic
hyperglycemia is a major cause of complications of dia-
betes through 5 major mechanisms including polyol
pathway, the formation of advanced glycation end prod-
ucts (AGEs), increased expression of AGEs receptor,
Protein kinase C isoform activation and hexosamine
pathway [1,2]. In general, non-enzymatic glycation is a
complex series of reactions between the carbonyl group
of reducing sugars (glucose, fructose, and ribose) and
the amino group of proteins. Consequently, a reversible
structure called as an unstable Schiff ’s base is formed
and spontaneously rearranged into an Amadori product
such as fructosamine. During the propagation reaction,
the Amadori products react with the amino acids to
form irreversible AGEs, including fluorescent and
crosslinking AGEs (such as pentosidine and imidazo-
lones) and non-fluorescent and non-crosslinking AGEs
(such as Nε-CML) [3-5]. The accumulation of AGEs in
living organisms also contributes to functional modifi-
cations of tissue proteins, resulting in the progress of
normal aging and the pathogenesis of age-related
diseases, such as diabetes, cardiovascular diseases, and
Alzheimer’s disease [6-8]. Fructose is one of the most
common reducing monosaccharides found in blood cir-
culation. Evidence supports that high fructose overcon-
sumption has been associated with an increased risk of
developing long-term diabetic complications [9,10].
Intracellular fructose is increased in a number of tissues
in diabetic patients via the polyol pathway, resulting in
glycation production approximately 10 times faster than
glucose [11]. Therefore, there has been serious concern re-
garding the critical role of dietary fructose in metabolic
diseases. Scientists are developing an alternative approach
to preventing progression of diabetic complications
through the reduction of AGE formation. Aminoguanidine
(AG), a well-known antiglycating agent, inhibits the for-
mation of AGEs and prevents the development of diabetic
complications in animal models of diabetes. Nevertheless,
aminoguanidine has been terminated due to serious
adverse effects such as myocardial infarction, congestive
heart failure, atrial fibrillation, anemia, and gastrointestinal
disturbance [12,13]. There has been a great deal of interest
in using plant-based foods for prevention and amelior-
ation of AGE-mediated diabetic complications [4,14,15].
Clitoria ternatea L. (Family: Fabaceae) commonly
known as butterfly pea has been used as a traditional
Ayurvedic medicine as a memory enhancer, antistress,
anxiolytic, antidepressant, anticonvulsant, tranquilizing,
and sedative agent [14]. Its flower petal containing dietary
anthocyanins is used as a natural blue colorant in a
variety of foods. The extract of Clitoria ternatea pos-
sesses a wide range of pharmacological activities includ-
ing anti-oxidant, antimicrobial, anti-inflammatory,
antipyretic, anti-helminthic, and analgesic activities
[16,17]. In addition, aqueous extract of Clitoria ternatea
flower exerts anti-hyperglycemic effects in alloxan-
induced diabetic rats [18]. To the best of our knowledge,
there have been no previous studies that address the effect
of Clitoria ternatea extract (CTE) on the inhibition of
AGE formation. Therefore, the objective of the present
study was to investigate the effect of CTE against bovine
serum albumin (BSA) in fructose-induced non-enzymatic
glycation. The study also examined the effect of CTE on
glycation-induced protein oxidative damages. Antioxidant
activity of CTE was also determined in various in vitro
models.
Methods
Chemicals
Bovine serum albumin (BSA), aminoguanidine (AG),
2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) (Trolox), 2,4,
6- tripyridyl-S-triazine (TPTZ), iron (II) sulfate (FeSO4),
xanthine, xanthine oxidase, 5,5′-dithiobisnitro benzoic
acid (DTNB), nitroblue tetrazolium (NBT), 1-deoxy-1-
morpholinofructose (DMF), 2,4-dinitrophenylhydrazine
(DNPH), thioflavin T reagent (4-(3,6-dimethyl-1,3-ben-
zothiazol-3-ium-2-yl)-N,N-dimethylaniline chloride), and
L-cysteine were purchased from Sigma Chemical Co.
(St. Louis, MO, USA). Fructose, Folin-Ciocalteu’s phenol
reagent, and gallic acid were purchased from Fluka
(St. Louis, MO, USA). All other chemical reagents used in
this study were of analytical grade.
Plant materials
The dried flower of Clitoria ternatea was purchased
from the local herbal shop in Bangkok, Thailand. The
plant has been authenticated at the Princess Sirindhorn
Plant Herbarium, Plant Varieties Protection Division,
Department of Agriculture, Thailand, Voucher specimen:
BKU066793. The extraction of the plant was modified
according to a previously published method [19]. Briefly,
the dried plant (300 g) was extracted with distilled water
(1 L) at 95°C for 2 h. The sample was filtered through
Whatman 70 mm filter paper. The aqueous solution was
dried using a spray dryer SD-100 (Eyela world, Tokyo
Rikakikai Co., LTD, Japan). The spray drying condition
was inlet temperature (178°C), outlet temperature (80°C),
blower (0.9 m3/min) and atomizing (90 kPa).
The phytochemical analysis
The CTE was dissolved in distilled water before use. For
measurement of total phenolic content, the sample was
mixed with Folin-Ciocalteu reagent (previously diluted
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10-fold with distilled water), followed by 2% Na2CO3
and kept for 2 h at room temperature. The absorbance of
mixture was measured at the wavelength 760 nm with a
spectrophotometer. Total phenolic content was expressed
as mg gallic acid equivalents/g dry weight of extract [19].
Quantification of flavonoid constituents was performed
according to a previously published method [19]. The
extract was dissolved in 95% ethanol and 10% aluminum
chloride, 1 M potassium acetate and distilled water, then
kept at room temperature for 30 min. The mixture was
measured the absorbance at the wavelength 415 nm with
a spectrophotometer. Catechin was used as the standard.
Total anthocyanin content (TAC) in the extract was deter-
mined by using pH differential method. The extract was
added to two buffer systems including 0.025 M potassium
chloride at pH 1.0 and 0.4 M sodium acetate at pH 4.5, re-
spectively. The calculated absorption was determined using
the equation of A = (A510 - A700) pH1.0 - (A510 - A700)
pH4.5 and the TAC in the testing solution was calculated
as cyanidin-3-glucoside equivalents [20].
Antiglycation activities
The glycated BSA formation was performed according
to a previously published method [21]. In brief, BSA
(10 mg/ml) was incubated with 0.5 M fructose in 0.1 M
phosphate buffered saline (PBS), pH 7.4 containing 0.02%
sodium azide in the dark at 37°C for 7, 14, 21, and 28 days.
Before incubation, CTE (0.25-1.00 mg/ml) and aminogua-
nidine (1.00 mM) were dissolved in PBS and added to the
mixtures. The fluorescent AGE formation of glycated BSA
was determined using a spectrofluorometer at excitation
and emission wavelength of 355 nm and 460 nm, respect-
ively. Aminoguanidine (AG) was used as a positive control
in this study. The results were expressed as a percentage
inhibition of the corresponding control values.
Determination of fructosamine
After incubation for 7, 14, 21, and 28 days, the concen-
tration of fructosamine was determined using a nitro-
blue tetrazolium (NBT) assay according to a previous
study [21]. In brief, the glycated BSA was incubated with
0.5 mM NBT in 2 M sodium carbonate buffer (pH 10.4) at
37°C for 10 and 15 min time points. The absorbance was
measured at the wavelength of 590 nm. The concentration
of fructosamine (mg/ml) was calculated from the standard
curve using 1-deoxy-1-morpholino-fructose (1-DMF).
Determination of protein carbonyl content
After incubation for 7, 14, 21, and 28 days, the protein
carbonyl content was determined using 2,4-dinitrophenyl-
hydrazine (DNPH) according to a previous study [21].
Briefly, the glycated BSA was incubated with 10 mM
DNPH in 2.5 M HCl in a dark room for 1 h. Protein pre-
cipitation was done by 20% w/v trichloroacetic acid (TCA)
on ice for 5 min and centrifuged at 10,000 rpm at 4°C for
10 min. The protein pellet was washed with 0.5 ml of
ethanol/ethyl acetate mixture (1:1 v/v) three times and then
dissolved in 6 M of guanidine hydrochloride (pH 2.3). The
absorbance was measured at wavelength of 370 nm. The
carbonyl content was calculated from the extinction coeffi-
cient for DNPH (ε = 22,000 M−1 · cm−1). The results were
expressed as nmol carbonyls/mg protein.
Determination of protein thiol group
After incubation for 7, 14, 21, and 28 days, the free thiol
concentration of glycated BSA was measured using
Ellman’s assay [21]. Briefly, the glycated samples were
incubated with 2.5 mM DTNB solutions for 15 min and
then the absorbance was read at wavelength of 410 nm.
The free thiol concentration of samples was calculated
based on the standard curve prepared by using various
concentration of L-cysteine.
DPPH radical scavenging activity
DPPH (1,1-diphenyl 2-picrylhydrazyl) radical scavenging
activity was measured according to the previous method
[22]. Briefly, the extract was added with 0.2 mM DPPH
as the free radical source and incubated for 30 min at
room temperature. The decrease in the solution absorb-
ance was measured at 515 nm. The IC50 value was cal-
culated from plots of log concentration of inhibitor
concentration versus percentage inhibition curves. As-
corbic acid was used as a positive control for this study.
Trolox equivalent antioxidant capacity assay (TEAC)
Assessment of ABTS radical-scavenging activity was
done according to a previously published method [22].
The radical anion (ABTS°+) was induced by adding
potassium persulfate (K2S2O4) and ABTS. The mixture
was incubated at room temperature for at least 16 hours
in the dark. The ABTS°+ solution was diluted in 0.1 M
PBS, pH 7.4 to absorbance at 0.700 ± 0.02 nm. The extract
was added to ABTS°+ solution for hydrogen atom transfer
(HAT). The decrease in the solution absorbance was
measured at 734 nm. The TEAC value was calculated
from the standard curve prepared by using a Trolox.
Ferric reducing antioxidant power (FRAP)
The reducing power was measured according to a previous
method [22]. The freshly FRAP reagent contained 0.3 M
sodium acetate buffer solution (pH 3.6), 10 mM 2,4,
6- tripyridyl-S-triazine (TPTZ) in 40 mM HCl and 20 mM
FeCl3. The extract was added to FRAP solution as oxidizing
reagent and incubated for 30 min at 37°C. The increase in
the solution absorbance was measured at 595 nm using a
spectrophotometer. FRAP value was calculated from a
standard curve using FeSO4. FRAP value was expressed as
mmol FeSO4/mg dried extract.
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Hydroxyl radical scavenging activity (HRSA)
Hydroxyl radical scavenging activity was measured ac-
cording a previous method [22]. The absorbance was
measured at 532 nm. The IC50 value was calculated from
plots of log concentration of inhibitor concentration ver-
sus percentage inhibition curves. A trolox was used as a
positive control for this study.
Superoxide radical scavenging activity (SRSA)
Superoxide radical scavenging activity was measured ac-
cording a previous method [22]. The absorbance was
measured at 560 nm. The IC50 value was calculated from
plots of log concentration of inhibitor concentration ver-
sus percentage inhibition curves. A trolox was used as a
positive control for this study.
Ferrous ion chelating power
The metal chelating power was measured according to
a previously published method [20]. The decrease in
the solution absorbance was measured at 522 nm. The
IC50 value was calculated from plots of log concentra-
tion of inhibitor concentration versus percentage in-
hibition curves. EDTA was used as a positive control
for this study.
Statistical analysis
Data were expressed as the mean ± standard error of
mean (SEM) for n = 5. The results were analyzed by
one-way analysis of variance (ANOVA) and Duncan’s
post hoc analysis. p < 0.05 was considered to be statisti-
cally significant.
Results
Phytochemical analysis
The content of total phenolic compounds in CTE was
53 ± 0.34 mg gallic acid equivalents/g dried extract. The
content of flavonoid in CTE was 11.2 ± 0.33 mg catechin
equivalents/g dried extract. Moreover, the content of
total anthocyanin in CTE was 1.46 ± 0.04 mg cyanidin-3-
glucoside equivalents/g dried extract.
Antiglycation activity of CTE
Figure 1 shows the effects of CTE (0.25-1.00 mg/ml) on
the formation of fluorescent AGEs at 7, 14, 21, and
28 days of incubation. Compared with BSA, the fluores-
cent intensity of glycated BSA was 1.6-fold, 1.7-fold, 3.5-
fold, and 6.8-fold higher than non-glycated BSA after
days 7, 14, 21, and 28, respectively. When CTE was
added to the solution, the formation of AGEs was sup-
pressed in a concentration-dependent manner during
14–28 days of incubation. At day 28, the percentage in-
hibition of CTE at concentration of 0.25, 0.50, and
1.00 mg/ml was 18.35%, 26.40%, and 49.40%, respect-
ively (Figure 2). In the meantime, AG (1.00 mg/ml)
inhibited AGE formation by 93.45 ± 0.45%.
The effect of CTE on the level of fructosamine
The level of fructosamine in glycated BSA was gradually
increased 2.0-fold to 3.6-fold during 28 days of incuba-
tion (Figure 3). CTE showed a significant reduction in
fructosamine level in glycated BSA throughout the incu-
bation period. At day 28, the percentage reduction of
fructosamine level by CTE (0.25-1.00 mg/ml) was in the
Figure 1 The effects of CTE (0.25-1.00 mg/ml) and aminoguanidine (1.00 mg/ml) on fluorescent AGE formation in BSA/fructose system.
Each value represented the mean ± SEM (n = 5). ap < 0.05 compared to BSA, bp < 0.05 compared to BSA + Fr (Fructose).
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range of 14.47% to 35.66% while AG at a concentration
of 1.00 mg/ml had the percentage reduction of 25.96%.
The effect of CTE on protein carbonyl content
Figure 4 shows the effect of CTE on protein carbonyl
content represented as an oxidative modification of
BSA. The carbonyl content of glycated BSA was signifi-
cantly increased during the experimental period
(3.0-fold to 9.4-fold increase) whereas BSA/fructose
together with CTE (0.25–1.00 mg/ml) significantly at-
tenuated an increase in the protein carbonyl content of
BSA. Compared to non-glycated BSA at day 28 of incu-
bation, the carbonyl content was reduced by CTE at
concentrations of 0.25-1.00 mg/ml with the range of
8.23% to 11.34%, whereas that by AG showed a
percentage of 17.71%.
Figure 2 The percentage inhibition of CTE (0.25-1.00 mg/ml) and aminoguanidine (1.00 mg/ml) on fluorescent AGE formation in
BSA/fructose system. Each value represented the mean ± SEM (n = 5).
Figure 3 The effects of CTE (0.25-1.00 mg/ml) and aminoguanidine (1.00 mg/ml) on the level of fructosamine in BSA/fructose system.
Each value represented the mean ± SEM (n = 5). ap < 0.05 compared to BSA, bp < 0.05 compared to BSA + Fr (Fructose).
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The effect of CTE on protein thiol group
The structural alteration in BSA mediated by protein
glycation is commonly detected by depleting the thiol
group. When BSA was incubated with fructose, the
level of thiol groups continuously decreased through-
out the experimental period. From day 7 to 28, the
percentage of depleting thiol group was in the range of
50.3%-91.6% (Figure 5). The results demonstrated that
CTE at the concentration of 0.25–1.00 mg/ml signifi-
cantly attenuated the depleting protein thiol group of
glycated BSA during the study. At day 28, the percent-
age prevention of depleting thiol groups by CTE was in
the range of 23.47% to 45.6% whereas AG significantly
prevented the depletion of protein thiol groups
by 79.57%.
Antioxidant activity
In DPPH assay, CTE had significant radical scavenging
activity with the IC50 value of 0.47 ± 0.01 mg/ml (Table 1).
The results indicated that CTE had 235-times less
potency than that observed for ascorbic acid (0.002 ±
0.001 mg/ml). According to the results from TEAC and
FRAP, CTE had the ability of 0.17 ± 0.01 mg trolox
equivalents/mg dried extract and 0.38 ± 0.01 mmol
FeSO4 equivalents/mg dried extract, respectively. In the
SRSA assay, the IC50 value of CTE was found to be
26.31 ± 4.22 mg/ml. However, CTE had 45-times less
potency than trolox (0.58 ± 0.04 mg/ml). The results
showed that CTE exhibited less potent antioxidant
activity with FICP and HRSA.
Discussion
Albumin is a target protein for the glycation reaction
due to its abundance in serum [23]. Protein glycation
occurs by the covalent binding of aldehyde or ketone
groups of reducing sugars to the free amino groups of
proteins, leading to the formation of fluorescent AGEs
that can be identified by increasing fluorescent intensity
[20]. The level of the Amadori products can be deter-
mined by colorimetric assay. Our results in this experi-
ment showed that CTE effectively inhibited fructose-
induced fluorescent AGE formation in a concentration-
dependent manner. In addition, the inhibitory effect of
CTE consequently suppressed the formation of fructosa-
mine (Amadori adducts) and AGEs. Previous studies
have shown the ability of phenolic-enriched plant ex-
tracts against fructose-induced protein glycation [24,25].
For example, pomelo extract (0.25 – 1 mg/ml) inhibited
the overall formation of AGEs approximately 50-86%
[26]. At concentrations of 1 mg/ml, Beijing grass, penny-
wort, gingko, Cat’s Whiskers and grape seed containing
phenolic compounds and flavonoids had the percentage
inhibition of protein glycation ranging 17-41%
at week 4 of experiments [27]. Mesona chinensis Benth
(Chinese Mesona), most widely consumed as an herbal
beverage and a gelatin-type dessert, also showed the per-
centage inhibition of 39.60-59.42% with concentration of
0.25-1.00 mg/mL at week 4 of incubation [28]. Our find-
ings suggest that CTE is a moderate antiglycating agent
in comparison with other phenolic-enriched extracts.
Abundant evidence exists that an excessive production
of reactive oxygen species (ROS) and reactive nitrogen
Figure 4 The effects of CTE (0.25-1.00 mg/ml) and aminoguanidine (1.00 mg/ml) on the level of protein carbonyl in BSA/fructose
system. Each value represented the mean ± SEM (n = 5). ap < 0.05 compared to BSA, bp < 0.05 compared to BSA + Fr (Fructose).
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species are generated during glycation and glycoxidation
[3-5] The production of ROS causes the oxidation of
amino acid residues of protein to form a carbonyl de-
rivative, which diminishes the oxidative defence of pro-
tein by eliminating the thiol groups [29,30]. In the
present study, the protein oxidation was observed by
increasing protein carbonyl content and depleting pro-
tein the thiol group of BSA. Conversely, the reduction of
protein carbonyl content and oxidation of thiol group of
BSA/fructose system was affected by CTE. Evidence
supports that the formation of AGEs could generate free
radicals and highly reactive intermediates in the early
stages of glycation [31]. Moreover, the Amadori products
subsequently degrade into α-dicarbonyl compounds such
as methylglyoxal, glyoxal, and deoxyglucosones. These
compounds are more reactive than the reducing sugars
with respect to their ability to react with amino groups
of proteins and consequently generate the cross-linked
methylglyoxal dialkylimine radical cation and the enediol
radical anion of methylglyoxal, which leads to the forma-
tion of AGEs [32]. In addition, the methylglyoxal anions
directly react with molecular oxygen to generate the
superoxide anion radicals whereas hydroxyl radicals can
be generated during the reaction of methylglyoxal with
lysine in the presence of metal ions (Fe3+ and Cu2+) [32].
When ROS is increased from protein glycation reaction,
antioxidant enzymes (superoxidae dismutase, catalase,
and glutathione reductase) primarily account for intra-
cellular defense while non-enzyme antioxidants (vitamin
C and E) help protect various components against oxida-
tive damage in plasma [33]. Interestingly, it has been
shown that free radical scavengers from natural products
can act as non-enzyme antioxidants to prevent against
reducing sugar-induced glycation and oxidative modifi-
cation to protein [4]. Therefore, various antioxidant
activity methods have been used to investigate the free
radical scavenging ability of CTE. The findings indicate
that CTE exhibits the ability to scavenge different forms
Table 1 Antioxidant activity of CTE including DPPH radical scavenging activity, TEAC, FRAP, HRSA, SRSA, and FICP
Antioxidant activities
DPPH TEAC FRAP HRSA SRSA FICP
CTE 0.467 ± 0.005 0.168 ± 0.001 0.379 ± 0.009 19.18 ± 3.40 26.31 ± 4.22 >103
Ascorbic acid 0.002 ± 0.001 - - - - -
Trolox - - - 2.03 ± 0.04 0.574 ± 0.04 -
EDTA - - - - - 8.88 ± 1.60
Data are expressed as mean ± S.E.M, n = 3. DPPH radical scavenging activity, hydroxyl radical scavenging activity (HRSA), and superoxide radical scavenging activity
(SRSA) are expressed as the IC50 value (mg/ml). TEAC, FRAP, and FICP are expressed as mg trolox/mg dried extract, mmol FeSO4/mg dried extract, and mg EDTA/mg
dried extract, respectively.
Figure 5 The effects of CTE (0.25-1.00 mg/ml) and aminoguanidine (1.00 mg/ml) on the level of protein thiol group in BSA/fructose
system. Each value represented the mean ± SEM (n = 5). ap < 0.05 compared to BSA, bp < 0.05 compared to BSA + Fr (Fructose).
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of free radicals, thus suggesting that its potential use in
preventing formation of AGEs and oxidative modifica-
tion to protein is possibly as a result of free radical scav-
enging ability.
Phytochemical compounds including polyphenolics,
flavonoids and anthocyanins, present in plant-based
foods, provide beneficial effects on free radical scaven-
ging properties [34-36]. The phytochemical analysis of
Clitoria ternatea flower petal extract revealed the pres-
ence of bioactive compounds such as delphinidin-3,5-glu-
coside, delphinidin-3β-glucoside, malvidin-3β-glucoside,
kaemphferol, p-coumaric acid and six major ternatins
(ternatins A1, A2, B1, B2, D1 and D2) [37]. The previous
findings demonstrated in the phytochemical compounds
possibly contributing to anti-glycation and antioxidant
activity, the amount of phenolics and flavonoids in plant-
based foods is highly related to their activity [14,15,38]. In
the view of the above-mentioned, the probable mechanism
by which CTE exerts antiglycation and antioxidant activity
may be in association with the phytochemical compounds
in the extract. Other mechanisms of antiglycation,
particularly for inhibiting the formation of late-stage
Amadori products, breaking the cross-linking structures
in the intracellular formed AGEs, and blocking the
receptor for advanced glycation end products (RAGEs)
have been proposed [4]. Further comprehensive studies
of CTE are required to clarify the antiglycation mecha-
nisms described above.
Conclusions
In the present work, CTE prevents fructose-induced
protein glycation and oxidation-dependent damages to
protein. It also exhibits an excellent scavenging ability
for different forms of free radicals. Antiglycation and
antioxidant activity of CTE may be responsible for their
usefulness in the management and prevention of AGE-
mediated diabetic complication. Further studies are
required to investigate the antiglycative effects of CTE
on diabetic rats.
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